A pharmaceutical company wants to study the effectiveness of a new drug in treating migraine headaches. For its trial, it gathers randomly selected volunteers regardless of their age, gender, or race. Is this an appropriate, random sample on which the pharmaceutical company can rely to draw its conclusions?(1 point) Responses No, this is not an appropriate, random sample. The company should only run the trial on volunteers age 50 and older. No, this is not an appropriate, random sample. The company should only run the trial on volunteers age 50 and older. Yes, this is an appropriate, random sample. Yes, this is an appropriate, random sample. There is not enough information to determine whether this is an appropriate, random sample for the population in this scenario. There is not enough information to determine whether this is an appropriate, random sample for the population in this scenario. No, this is not an appropriate, random sample. The company should only run the trial on female volunteers because migraine headaches are more common in women.

1 answer

The most accurate response is:

There is not enough information to determine whether this is an appropriate, random sample for the population in this scenario.

While the company has selected a random sample of volunteers, we don't know if specific characteristics (like age or gender) significantly affect the drug's effectiveness for migraine treatment. Therefore, without further information about the inclusion criteria and the nature of the study, we cannot definitively conclude whether the sample is appropriate.